COUR Pharmaceuticals: The Race
to High-Value Engagement
"Decision-making is getting faster, which is good for patients but hard for the
industry. We need to support physicians to make decisions faster, and for
that companies need a seamless, agile communication path from the
clinic to the medical preparation and commercialization because
that's what customers expect."
Malcolm Crooks, COO of COUR Pharmaceuticals, discusses how to accelerate the shift to high-value engagement.
Discover more here to learn how the industry is achieving commercial excellence in sales, medical, and marketing.
